VPS Tg mice were subjected to the AOM/DSS cycle to investigate whether VPS9D1-AS1 acts as a therapeutic target (Figure 7L, Figure 7—figure supplement 1G). This evidence concerns the gene VPS9D1 and infectious otitis media.